H.R. 1362 · 116th Congress
Medical Innovation Never Stops Act of 2019
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 116th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
R
EmmerSponsorNo cosponsors.
This bill requires the Food and Drug Administration (FDA)to accept and review new medical device applications and associated user fees during a lapse in appropriations.Under current law, the FDA is prohibited from accepting new user fees and reviewing medical device submissions during an appropriations lapse.
What it does: CRS summary · Introduced in House · Feb 26, 2019
Medical Innovation Never Stops Act of 2019
This bill requires the Food and Drug Administration (FDA)to accept and review new medical device applications and associated user fees during a lapse in appropriations.Under current law, the FDA is prohibited from accepting new user fees and reviewing medical device submissions during an appropriations lapse.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Medical Innovation Never Stops Act of 2019
Latest action (Feb 27, 2019): Referred to the Subcommittee on Health.
Policy area: Health · Origin: House · Introduced: Feb 26, 2019
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.